Phase I Dose-Escalating Study of Combining Intravenous Tirapazamine and Transarterial Embolization (TAE) in Hepatocellular Carcinoma
Phase of Trial: Phase I
Latest Information Update: 23 Apr 2017
At a glance
- Drugs Tirapazamine (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- Sponsors Teclison
- 26 Aug 2015 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017 as reported by ClinicalTrials.gov record.
- 26 Aug 2015 Planned primary completion date changed from 1 Sep 2015 to 1 Dec 2016 as reported by ClinicalTrials.gov record.
- 26 Aug 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.